(Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | (FY)Dec 31, 2020 | (Q6)Jun 30, 2020 | (FY)Dec 31, 2019 | |
---|---|---|---|---|---|---|---|---|---|---|
Turnover | -20.05%34B | 2.51%119.46B | -1.89%42.53B | -31.26%116.54B | -45.68%43.35B | 16.03%169.54B | 110.53%79.8B | 68.24%146.12B | 115.96%37.91B | 58.54%86.85B |
Operating income | -20.05%34B | 2.51%119.46B | -1.89%42.53B | -31.26%116.54B | -45.68%43.35B | 16.03%169.54B | 110.53%79.8B | 68.24%146.12B | 115.96%37.91B | 58.54%86.85B |
Cost of sales | 22.61%-27.18B | -2.68%-103.3B | -1.21%-35.12B | 28.74%-100.6B | 47.24%-34.7B | -23.27%-141.18B | -125.61%-65.77B | -89.29%-114.53B | -157.74%-29.15B | -69.37%-60.51B |
Operating expenses | 22.61%-27.18B | -2.68%-103.3B | -1.21%-35.12B | 28.74%-100.6B | 47.24%-34.7B | -23.27%-141.18B | -125.61%-65.77B | -89.29%-114.53B | -157.74%-29.15B | -69.37%-60.51B |
Gross profit | -7.94%6.83B | 1.44%16.17B | -14.33%7.42B | -43.79%15.94B | -38.33%8.66B | -10.23%28.36B | 60.32%14.03B | 19.90%31.59B | 40.24%8.75B | 38.24%26.35B |
Selling expenses | 2.02%-1.65B | 6.29%-5.21B | 2.15%-1.68B | 6.38%-5.56B | 37.96%-1.72B | -6.78%-5.94B | -43.97%-2.77B | -25.73%-5.56B | -96.61%-1.92B | -86.25%-4.42B |
Administrative expenses | 18.05%-1.69B | 20.11%-4.15B | 12.39%-2.06B | -0.87%-5.19B | 8.57%-2.35B | -8.91%-5.15B | -15.32%-2.57B | -9.92%-4.73B | -63.73%-2.23B | -62.27%-4.3B |
Revaluation surplus | -151.84%-66.14M | -98.40%23.35M | -82.85%127.59M | -47.15%1.46B | 44.01%744.16M | 21.59%2.75B | -2.37%516.76M | -11.86%2.26B | -11.35%529.29M | -15.74%2.57B |
-Changes in the fair value of investment property | -151.84%-66.14M | -98.40%23.35M | -83.45%127.59M | -47.88%1.46B | 39.75%771.04M | 21.08%2.79B | -6.21%551.72M | -5.41%2.31B | -1.93%588.28M | -25.78%2.44B |
-Changes in the fair value of other assets | ---- | ---- | ---- | ---- | 23.14%-26.88M | 6.42%-38.99M | 40.73%-34.97M | -131.76%-41.66M | -2,001.78%-59M | 155.63%131.18M |
Impairment and provision | 234.77%72.2M | -182.33%-1.2B | -83.29%21.57M | 9.06%-424.11M | 136.30%129.09M | -194.19%-466.37M | -3,158.86%-355.62M | -7.95%-158.53M | 122.50%11.63M | 6.92%-146.85M |
-Other impairment is provision | 234.77%72.2M | -182.33%-1.2B | -83.29%21.57M | 9.06%-424.11M | 136.30%129.09M | -194.19%-466.37M | -3,158.86%-355.62M | -7.95%-158.53M | 122.50%11.63M | 6.92%-146.85M |
Special items of operating profit | -93.65%32.58M | 531.40%590.21M | 290.99%513.14M | -122.45%-136.81M | -31.27%131.24M | -2.67%609.35M | 21.37%190.94M | -39.00%626.09M | 50.16%157.32M | 12.26%1.03B |
Operating profit | -18.59%3.53B | 2.38%6.22B | -22.43%4.34B | -69.85%6.08B | -38.19%5.59B | -16.08%20.17B | 70.72%9.05B | 14.05%24.03B | 16.42%5.3B | 18.12%21.07B |
Financing income | -71.15%48.85M | -23.34%297.43M | -12.83%169.3M | -11.55%388.01M | -27.81%194.23M | -21.61%438.69M | -7.38%269.06M | 10.58%559.61M | 46.18%290.51M | 120.39%506.08M |
Financing cost | -19.06%-1.61B | 19.65%-3.04B | -8.10%-1.36B | -194.86%-3.78B | -14.37%-1.25B | -12.43%-1.28B | -16.18%-1.1B | 38.25%-1.14B | -38.92%-943.49M | -90.36%-1.85B |
Share of profits of associates | -42.66%167.04M | 80.65%692.83M | 276.37%291.32M | -43.66%383.51M | -275.40%-165.18M | -61.13%680.7M | -87.44%94.17M | -4.81%1.75B | 103.82%750.03M | 85.82%1.84B |
Share of profit from joint venture company | -35.23%201.09M | 35.37%840.16M | -19.69%310.45M | -55.40%620.66M | -13.44%386.58M | 17.68%1.39B | -3.97%446.59M | 2,071.97%1.18B | 264.89%465.06M | -90.27%54.44M |
Earning before tax | -37.80%2.33B | 35.87%5.02B | -21.04%3.75B | -82.73%3.69B | -45.74%4.75B | -18.91%21.4B | 49.46%8.76B | 22.01%26.39B | 28.34%5.86B | 15.97%21.63B |
Tax | 34.85%-944.04M | -85.88%-5.49B | 19.16%-1.45B | 63.27%-2.95B | 56.29%-1.79B | 21.73%-8.04B | -73.03%-4.1B | -13.84%-10.27B | -27.49%-2.37B | -36.65%-9.02B |
After-tax profit from continuing operations | -39.66%1.39B | -162.88%-467.03M | -22.17%2.3B | -94.44%742.7M | -36.46%2.96B | -17.11%13.36B | 33.46%4.66B | 27.86%16.12B | 28.93%3.49B | 4.64%12.61B |
After-tax profit from non-continuing business | ---- | --1.25B | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
Earning after tax | -39.66%1.39B | 5.64%784.57M | -22.17%2.3B | -94.44%742.7M | -36.46%2.96B | -17.11%13.36B | 33.46%4.66B | 27.86%16.12B | 28.93%3.49B | 4.64%12.61B |
Minority profit | -50.61%431.26M | -120.50%-94.72M | -25.48%873.22M | -90.31%462.03M | -32.85%1.17B | -19.69%4.77B | 0.68%1.74B | 23.91%5.94B | 46.89%1.73B | -9.32%4.79B |
Profit attributable to shareholders | -32.97%959.24M | 213.28%879.3M | -20.01%1.43B | -96.73%280.67M | -38.62%1.79B | -15.60%8.59B | 65.77%2.91B | 30.29%10.18B | 15.07%1.76B | 15.55%7.81B |
Basic earnings per share | -30.00%0.14 | 200.00%0.12 | -28.57%0.2 | -97.12%0.04 | -40.43%0.28 | -15.76%1.39 | 67.86%0.47 | 25.00%1.65 | 7.69%0.28 | 14.78%1.32 |
Diluted earnings per share | -30.00%0.14 | 200.00%0.12 | -28.57%0.2 | -97.10%0.04 | -40.43%0.28 | -16.36%1.38 | 67.86%0.47 | 25.00%1.65 | 7.69%0.28 | 17.86%1.32 |
Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion |
Auditor | -- | PricewaterhouseCoopers | -- | PricewaterhouseCoopers | -- | PricewaterhouseCoopers | -- | PricewaterhouseCoopers | -- | PricewaterhouseCoopers |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
No Data
No Data